N.Y.-based startup Eyenovia updated its regulatory filings to reveal that it plans to offer 2.73 million shares priced between $10 – $12 apiece in its initial public offering.
The 7-person company, which is developing a device to deliver small doses of drugs to the eye, is applying to list on the Nasdaq exchange under the symbol, “EYEN”.
Get the full story at our sister site, Drug Delivery Business News.
The post Eyenovia sets range for IPO appeared first on MassDevice.